Showing results (161-170 of 241) with videos related to
Sort By:
Pageof 25
BMC Infectious Diseases|February 19, 2025
Patient preferences for long-acting HIV treatment: a preference heterogeneity assessmentEnrique M Saldarriaga, Brett Hauber, Douglas Barthold, et al.Journal of Patient Experience|November 29, 2023
Priority Outcomes in Sickle Cell Disease Treatment: Co-Creation and Implementation of a Preference Exercise With Patients and Caregivers to Inform Drug DevelopmentMaggie Jalowsky, Brett Hauber, Mariah Jacqueline Scott, et al.Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|January 15, 2015
A survey of patient preferences for oral antihyperglycemic therapy in patients with type 2 diabetes mellitusA Brett Hauber, Kaan Tunceli, Jui-Chen Yang, et al.Patient Preference and Adherence|June 26, 2024
Patient Acceptability and Preferences for Solid Oral Dosage Form Drug Product Attributes: A Scoping ReviewBrett Hauber, Mark V Hand, Bruno C Hancock, et al.Expert Review of Pharmacoeconomics & Outcomes Research|April 4, 2015
Discrete-choice experiments versus rating scale exercises to evaluate the importance of attributesBen Fm Wijnen, Inge M van der Putten, Siebren Groothuis, et al.Alzheimer Disease and Associated Disorders|August 30, 2008
Older Americans' risk-benefit preferences for modifying the course of Alzheimer diseaseA Brett Hauber, F Reed Johnson, Howard Fillit, et al.Pharmacoeconomics|October 19, 2021
Mogamulizumab for Previously Treated Mycosis Fungoides and Sézary Syndrome: An Evidence Review Group Perspective of a NICE Single Technology AppraisalSabine E Grimm, Willem Witlox, Robert Wolff, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 26, 2025
A Patient Preference-Weighted Quantitative Benefit-Risk Analysis of Ritlecitinib for Alopecia Areata to Inform Medical Decision MakingJonathan Mauer, Chiara Whichello, Brett Hauber, et al.Pulmonary Therapy|October 28, 2024
Perspectives on Drug Product Design Among Patients with Lung Cancer in the United KingdomJoshua R Coulter, Louis Edward Baig, Amy Antipas, et al.The Patient|August 30, 2023
Maximum Acceptable Risk Estimation Based on a Discrete Choice Experiment and a Probabilistic Threshold TechniqueJorien Veldwijk, Rachael Lynn DiSantostefano, Ellen Janssen, et al.Pageof 25